Your account is not claimed yet. You can sign up with ORCID to claim your account.

Megane Vernon (Mégane Vernon)

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Basal Cell Carcinoma

Top Venues

Molecular cancer research : MCR

Cancer research

Molecular cancer therapeutics

Laboratoire INSERM U1199 BioTICLA

Normandie Université (MSC)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Laboratoire INSERM U1199 BioTICLA Oct 1o 2016

France

Etudiante doctorante :: 14

Education History

Normandie Université Sep 1o 2014 - Jul 1o 2015

France

MSC :: 14

Publications

Weijia Cai, Mai Q Nguyen, Nicole A Wilski, Timothy J Purwin, Megane Vernon, Manoela Tiago, Andrew E Aplin
A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma. Cancer research 82 (14) (2022)
Megane Vernon, Nicole A Wilski, Daniel Kotas, Weijia Cai, Danielle Pomante, Manoela Tiago, Emad S Alnemri, Andrew E Aplin
Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naïve and Therapy-Resistant Melanoma. Molecular cancer research : MCR 20 (12) (2022)
Megane Vernon, Bernard Lambert, Matthieu Meryet-Figuière, Emilie Brotin, Louis-Bastien Weiswald, Hippolyte Paysant, Nicolas Vigneron, Anaïs Wambecke, Edwige Abeilard, Florence Giffard, Marie-Hélène Louis, Cécile Blanc-Fournier, Pascal Gauduchon, Laurent Poulain, Christophe Denoyelle
Functional miRNA Screening Identifies Wide-ranging Antitumor Properties of miR-3622b-5p and Reveals a New Therapeutic Combination Strategy in Ovarian Tumor Organoids. Molecular cancer therapeutics 19 (7) (2020)